Vitamin D Market Report 2026

Vitamin D Market Report 2026
Global Outlook – By Type (Vitamin D3, Vitamin D2), By IU Strength (500,000 IU, 100,000 IU, 40 MIU), By Form (Oil, Powder), By End User (Adults, Pregnant Women, Children) – Market Size, Trends, Strategies, and Forecast to 2035
Vitamin D Market Overview
• Vitamin D market size has reached to $1.79 billion in 2025 • Expected to grow to $2.92 billion in 2030 at a compound annual growth rate (CAGR) of 10.3% • Growth Driver: Osteoporosis Surge In Women Fuels Demand For Vitamin D Driving Growth In The Market • Market Trend: Revolutionizing The Vitamin D Market Emergence Of Faster-Acting Vitamin D Supplements • North America was the largest region in 2025.What Is Covered Under Vitamin D Market?
Vitamin D refers to a nutrient that the body needs in small amounts to operate and maintain health. The body uses calcium and phosphorus with the aid of vitamin D to build healthy bones and teeth. It can dissolve in fats and oils and is present in dairy products, fatty fish, and egg yolks. It also helps to maintain good bone structure and strength. The main types of vitamin D include vitamin D3 and vitamin D2. Vitamin D3 is mainly obtained from animal-sourced foods such as oil, egg yolk, butter and dietary supplements. It is also called cholecalciferol and helps the body to absorb calcium. It is mainly used to treat people having disorders such as osteomalacia or rickets. Vitamin D is available in three IU strength ranging from 500,000 IU, 100,000 IU and 40 MIU and comes in oil form and powder form. It is used for adults, pregnant women and children.
What Is The Vitamin D Market Size and Share 2026?
The vitamin d market size has grown rapidly in recent years. It will grow from $1.79 billion in 2025 to $1.97 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to increasing prevalence of vitamin d deficiency, growing awareness of bone-related disorders, rising consumption of dairy and fortified foods, expansion of pharmaceutical manufacturing, increased research on nutritional supplements.What Is The Vitamin D Market Growth Forecast?
The vitamin d market size is expected to see rapid growth in the next few years. It will grow to $2.92 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to adoption of personalized nutrition, growth of direct-to-consumer supplement platforms, advancements in vitamin d formulation technologies, increasing health-conscious population, expansion in emerging markets. Major trends in the forecast period include rising awareness of bone health, fortification of foods with vitamin d, personalized nutrition and supplementation, growth in pediatric and geriatric supplement use, expansion of online nutraceutical sales.Global Vitamin D Market Segmentation
1) By Type: Vitamin D3, Vitamin D2 2) By IU Strength: 500,000 IU, 100,000 IU, 40 MIU 3) By Form: Oil, Powder 4) By End User: Adults, Pregnant Women, Children Subsegments: 1) By Vitamin D3: Cholecalciferol (Natural Source), Synthetic Vitamin D3 2) By Vitamin D2: Ergocalciferol (Natural Source), Synthetic Vitamin D2What Is The Driver Of The Vitamin D Market?
The rise in incidences of osteoporosis in women will propel the growth of the vitamin D market. Osteoporosis is a bone disease caused by a reduction in bone mineral density and mass and a change in the quality or structure of bone. It is usually caused by a lack of calcium and vitamin D in the body, which increases the risk of fractures, while other reasons include a family history of osteoporosis, parental history of hip fracture, lower body mass index (BMI), female gender due to smaller, thinner bones than men, and others. The rising prevalence of osteoporosis in women will lead to high demand for vitamin D, as it is an essential nutrient that helps the body absorb calcium and phosphorus from the food eaten and build stronger bones in women after menopause. It also helps treat diseases that cause weak bones. For instance, in September 2023, according to the National Center for Biotechnology Information, a US-based government agency, data from the Canadian Longitudinal Study on Aging shows that the prevalence of physician-diagnosed osteoporosis was 12.7% and DXA-confirmed osteoporosis was 5.9% in females among community-dwelling older adults. Additionally, Buttros and colleagues conducted a cross-sectional study that revealed a 24.6% prevalence of osteoporosis in postmenopausal women aged 40 to 75, diagnosed using bone mineral density (BMD) measurements. Thus, the rise in incidences of osteoporosis in women will drive the vitamin D industry growth.Key Players In The Global Vitamin D Market
Major companies operating in the vitamin d market are BASF SE, Koninklijke DSM NV, Fermenta Biotech Ltd., Xiamen Kingdomway Vitamin Co. Ltd., Zhejiang Medicine Co. Ltd., Abbott Laboratories, Bayer AG, Bluebonnet Nutrition, Carlson Labs, Country Life LLC, Doctor's Best Inc., Douglas Laboratories, Garden of Life LLC, GlaxoSmithKline plc, Jarrow Formulas, Kirkland Signature, Life Extension, Merck & Co. Inc., Metagenics LLC, Pharmavite LLC, Nature's Bounty Co. Ltd., Nestlé Health Science SA, Pfizer Inc., Protocol for Life Balance Inc., Pure Encapsulations Inc., Sanofi S. A., Source Naturals Inc., Sundown Naturals Inc., Swanson Health Products Inc., Twinlab Consolidated Corporation, Vital Nutrients Company Inc.Global Vitamin D Market Trends and Insights
Major companies operating in the vitamin D market are focusing on developing innovative solutions, such as faster-acting vitamin D formulations, to meet the rising demand for rapid correction of severe vitamin D deficiency and improved treatment outcomes. Faster-acting vitamin D products are designed to achieve quicker serum vitamin D elevation compared with conventional oral or oil-based preparations, offering enhanced absorption, faster onset of action, and better support for patients requiring urgent replenishment. For instance, in February 2024, Cadila Pharmaceuticals Ltd., an India-based pharmaceutical company, launched an aqueous vitamin D injection. The innovative aqueous formulation of cholecalciferol provides a quick resolution of vitamin D deficiency, featuring enhanced pharmacokinetics and pharmacodynamics over traditional oil-based preparations while ensuring painless administration. This advancement meets the urgent need for faster treatment outcomes, improving patient compliance with their regimens.What Are Latest Mergers And Acquisitions In The Vitamin D Market?
In April 2023, Innovad, a Belgium-based provider of animal nutrition and health solutions, acquired Herbonis AG for an undisclosed amount. Through this acquisition, Innovad aims to strengthen its natural specialty feed ingredient portfolio by integrating Herbonis’s plant-based vitamin D products, including Panbonis, and expanding its offerings in vitamin D supplementation for animal nutrition. Herbonis AG is a Switzerland-based company that provides plant-based sources of the metabolically active form of vitamin D.Regional Insights
North America was the largest region in the vitmain D market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Vitamin D Market?
The vitamin D market consists of sales of ergocalciferol, cholecalciferol, and pre-vitamin D. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Vitamin D Market Report 2026?
The vitamin d market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vitamin d industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Vitamin D Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.97 billion |
| Revenue Forecast In 2035 | $2.92 billion |
| Growth Rate | CAGR of 10.2% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, IU Strength, Form, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | BASF SE, Koninklijke DSM NV, Fermenta Biotech Ltd., Xiamen Kingdomway Vitamin Co. Ltd., Zhejiang Medicine Co. Ltd., Abbott Laboratories, Bayer AG, Bluebonnet Nutrition, Carlson Labs, Country Life LLC, Doctor's Best Inc., Douglas Laboratories, Garden of Life LLC, GlaxoSmithKline plc, Jarrow Formulas, Kirkland Signature, Life Extension, Merck & Co. Inc., Metagenics LLC, Pharmavite LLC, Nature's Bounty Co. Ltd., Nestlé Health Science SA, Pfizer Inc., Protocol for Life Balance Inc., Pure Encapsulations Inc., Sanofi S. A., Source Naturals Inc., Sundown Naturals Inc., Swanson Health Products Inc., Twinlab Consolidated Corporation, Vital Nutrients Company Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Vitamin D market was valued at $1.79 billion in 2025, increased to $1.97 billion in 2026, and is projected to reach $2.92 billion by 2030.
request a sample hereThe global Vitamin D market is expected to grow at a CAGR of 10.3% from 2026 to 2035 to reach $2.92 billion by 2035.
request a sample hereSome Key Players in the Vitamin D market Include, BASF SE, Koninklijke DSM NV, Fermenta Biotech Ltd., Xiamen Kingdomway Vitamin Co. Ltd., Zhejiang Medicine Co. Ltd., Abbott Laboratories, Bayer AG, Bluebonnet Nutrition, Carlson Labs, Country Life LLC, Doctor's Best Inc., Douglas Laboratories, Garden of Life LLC, GlaxoSmithKline plc, Jarrow Formulas, Kirkland Signature, Life Extension, Merck & Co. Inc., Metagenics LLC, Pharmavite LLC, Nature's Bounty Co. Ltd., Nestlé Health Science SA, Pfizer Inc., Protocol for Life Balance Inc., Pure Encapsulations Inc., Sanofi S. A., Source Naturals Inc., Sundown Naturals Inc., Swanson Health Products Inc., Twinlab Consolidated Corporation, Vital Nutrients Company Inc. .
request a sample hereMajor trend in this market includes: Revolutionizing The Vitamin D Market Emergence Of Faster-Acting Vitamin D Supplements. For further insights on this market.
request a sample hereNorth America was the largest region in the vitmain D market in 2025. The regions covered in the vitamin d market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here